Integra is a leader in neurosurgery, offering a broad portfolio of devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. Integra’s product portfolio also includes tissue products used for a wide range of indications that include: acute wound care such as trauma reconstruction, burn treatment, chronic wound management, hernia repair, and peripheral nerve protection and repair.Founded in 1989, Integra is headquartered in Princeton, New Jersey, and has over 3,000 employees worldwide. Integra shares trade on The NASDAQ Stock Market under the symbol IART.
For inquiries, please e-mail us at: custsvcnj@integralife.com
Codman was bought by Integra LifeSciences in 2017. Darman Rah Royan Company is the exclusive representative of codman brain shants in two models of Hakim and Certas in Iran.
The Codman Hakim Programmable Valve offers the ability to optimize the opening pressure of a shunt system before and after implantation. a shunted patient’s condition will often change over the course of their treatment making pressure changes necessary. The programmable valve allows a surgeon to non-invasively change the opening pressure between 30 mm H2o and 200 mm H2o in 18 steps; negating the need for revision surgery to alter the valve pressure.
The CERTASTM Plus Programmable Valve offers the ability to optimize the opening pressure of a shunt system before and after implantation. A shunted patient’s condition will often change over the course of their treatment making pressure changes necessary. The CERTAS Plus Programmable Valve allows a surgeon to non-invasively change the opening pressure to one of eight performance settings, which range from 1 (low pressure) to 7 (high pressure), plus performance setting 8, which is a "Virtual Off." This programmability may negate the need for revision surgery to alter the valve pressure. Testing shows that the valve mechanism is resistant to unintended changes in the setting in a 3 Tesla MRI.
